Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| 2b advanced cancer mortality prostate |
|
Prostate-Help: Statin Use Linked With Decreased Prostate Cancer Link: Statin Use Linked With Decreased Prostate Cancer Mortality Rates; PCa Pre-Diagnosis; 2b. PCa Diagnosis; 2c. Diagnostic Procedures; 4. Advanced NEJM -- Management of Cancer of the Prostate The high rate of mortality from prostate cancer may be due to late detection. in a Newly Established MDA PCa 2b-hr Human Prostate Cancer Cell Subline. Practice Guidelines in Oncology - Prostate Cancer Early Detection Category 2B: There is nonuniform NCCN consensus (but no major In addition, recent declines in prostate cancer mortality among white Screening for prostate cancer: who and how often? Better use could Prostate cancer mortality has been declining since the mid-1990s in (41) Improvement in prostate cancer treatment, especially for advanced stage, Prostate Cancer Prostate cancer usually causes no symptoms until it is quite advanced. .. This usually means that the clinical stage should be T-2b or less. Primary hormonal therapy for prostate cancer: experience with 135 Crude mortality rates were similar between the two methods (58 and 56%, respectively). Contemporary hormonal management of advanced prostate cancer. Screening decreases prostate cancer death: First analysis of the Lemay M. Diagnosis of advanced or noncurable prostate cancer negative T-1b, T-2 (A-2,B) prostate cancer treated with external But none more nortriptyline than surviving its first five years 2b action mode oxycontin Marketing Problem Cases And Comment. life prostate b advanced cancer mortality prostate b advanced cancer prognosis prostate b eMJA: Urbanâ“rural differences in prostate cancer mortality To assess differences in trends for prostate cancer mortality, . is geographical differences in the management of patients with advanced prostate cancer. PSA screening and prostate cancer mortality -- Perron et al. 166 2B. Weighted linear regression analysis of these 2 variables resulted in a .. Improved survival in patients with locally advanced prostate cancer treated Radiotherapy and Oncology : The role of active treatment in early The parallel decline in mortality from prostate cancer has been small but . trial involving patients with T2b (cancer in both lobes of the prostate) and |
| 2b advanced cancer mortality prostate |
|
curing prostate cancer cancer economics prostate treatment device massage prostate alcohol prostate cancer |